{Reference Type}: Case Reports
{Title}: Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy.
{Author}: Endo Y;Soeda S;Yoshimoto Y;Todate Y;Hashimoto T;Furukawa S;Teranishi Y;Fujimori K;
{Journal}: J Surg Case Rep
{Volume}: 2024
{Issue}: 7
{Year}: 2024 Jul
暂无{DOI}: 10.1093/jscr/rjae452
{Abstract}: Stage IVA cervical cancer is a tumor that invades the mucosa of the bladder or rectum without distant metastasis and is difficult to treat, and concurrent chemoradiotherapy is recommended. Although radical surgery following neoadjuvant chemotherapy is a treatment option for stage IVA cervical cancer, the evidence is limited. A 51-year-old woman with bulky cervical cancer and rectal invasion was referred to our hospital. Paclitaxel and cisplatin were administered as neoadjuvant chemotherapies. After two cycles of chemotherapy, the tumor size decreased markedly. Total pelvic exenteration was performed, and a complete resection was achieved. Four cycles of paclitaxel and cisplatin were administered postoperatively. Thirty-three months after the completion of adjuvant chemotherapy, the patient was alive and free of disease. Radical surgery after neoadjuvant chemotherapy may be a treatment option for stage IVA cervical cancer with bulky tumors.